Nagaileben Co., Ltd. Stock price

Equities

7447

JP3647000003

Medical Equipment, Supplies & Distribution

Market Closed - Japan Exchange 02:00:00 2024-03-28 am EDT 5-day change 1st Jan Change
2,371 JPY -4.78% Intraday chart for Nagaileben Co., Ltd. -0.55% -0.46%
Sales 2022 17.74B 117M Sales 2023 17.18B 113M Capitalization 71.05B 469M
Net income 2022 3.78B 24.95M Net income 2023 3.23B 21.3M EV / Sales 2022 1.67 x
Net cash position 2022 28.56B 189M Net cash position 2023 27.16B 179M EV / Sales 2023 2.55 x
P/E ratio 2022
16.9 x
P/E ratio 2023
22.1 x
Employees 511
Yield 2022
3.07%
Yield 2023
2.72%
Free-Float 59.37%
More Fundamentals * Assessed data
Dynamic Chart
Nagaileben Co., Ltd. Provides Dividend Guidance for the Year Ending August 2024 CI
Nagaileben Co., Ltd. Provides Consolidated Earnings Guidance for the Six Months Ending February 2024 and the Fiscal Year Ending August 2024 CI
Tranche Update on Nagaileben Co., Ltd.'s Equity Buyback Plan announced on June 29, 2023. CI
Nagaileben Co., Ltd.'s Equity Buyback announced on June 29, 2023, has expired with 454,300 shares, representing 1.41% for ¥999.81 million. CI
Tranche Update on Nagaileben Co., Ltd.'s Equity Buyback Plan announced on June 29, 2023. CI
Nagaileben Co., Ltd. Provides Consolidated Earnings Guidance for the Six Months Ending Feb. 2024 and the Fiscal Year Ending August 2024 CI
Nagaileben Co., Ltd. Announces Dividend for the Year Ended August 2023; Payable on November 27, 2023; Provides Dividend Guidance for the Year Ending August 2024 CI
Tranche Update on Nagaileben Co., Ltd.'s Equity Buyback Plan announced on June 29, 2023. CI
Nagaileben Co., Ltd. announces an Equity Buyback for 500,000 shares, representing 1.55% for ¥1,000 million. CI
Nagaileben Co., Ltd. authorizes a Buyback Plan. CI
Nagaileben Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending August 31, 2023 CI
Nagaileben Co., Ltd. Provides Consolidated Earnings Guidance for the Six Months Ending February 2023 and Full Year Ending August 2023 CI
Nagaileben Co., Ltd. Provides Dividend Guidance for the Fiscal Year Ending August 31, 2023 CI
Nagaileben Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending August 31, 2023 CI
Nagaileben Co., Ltd. Provides Dividend Guidance for the Year Ending August 31, 2023 CI
More news
1 day-4.78%
1 week-0.55%
Current month+6.28%
1 month+3.49%
3 months-3.85%
6 months+11.31%
Current year-0.46%
More quotes
1 week
2 353.00
Extreme 2353
2 516.00
1 month
2 186.00
Extreme 2186
2 516.00
Current year
2 186.00
Extreme 2186
2 542.00
1 year
1 974.00
Extreme 1974
2 542.00
3 years
1 796.00
Extreme 1796
2 909.00
5 years
1 796.00
Extreme 1796
3 115.00
10 years
1 740.00
Extreme 1740
3 225.00
More quotes
Managers TitleAgeSince
President 67 80-03-31
Chief Administrative Officer 51 19-06-30
Chief Operating Officer 66 08-11-30
Members of the board TitleAgeSince
President 67 80-03-31
Director/Board Member 62 92-04-30
Director/Board Member 73 92-10-31
More insiders
Date Price Change Volume
24-03-28 2,371 -4.78% 27 200
24-03-27 2,490 +2.47% 55,700
24-03-26 2,430 +0.75% 23,500
24-03-25 2,412 +0.37% 26,600
24-03-22 2,403 +0.80% 16,400

Delayed Quote Japan Exchange, March 28, 2024 at 02:00 am EDT

More quotes
NAGAILEBEN Co., Ltd. is a Japan-based company mainly engaged in the medical wear business. The Company operates medical wear business. The medical wear business purchases and sells medical wear products used by medical professionals and care workers from subsidiaries. In addition, the Company is also engaged in the sale of shoes and other products.
Calendar
More about the company
Sell
Consensus
Buy
Mean consensus
SELL
Number of Analysts
1
Last Close Price
2,490 JPY
Average target price
2,000 JPY
Spread / Average Target
-19.68%
Consensus
  1. Stock
  2. Equities
  3. Stock Nagaileben Co., Ltd. - Japan Exchange